12:00 AM
 | 
Feb 20, 2001
 |  BC Week In Review  |  Clinical News  |  Regulatory

Monoclonal antibody to treat fibrin-containing tumors regulatory update

MABA received U.S. Patent No. 6,187,593 covering methods for using its MH-1 monoclonal antibody...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >